Share on:
Orthopedic M&A deals accelerated in 2023, according to ORTHOWORLD reporting. The jump in activity marks the first year-over-year increase since 2020, but still fell short of the 42 orthopedic transactions ORTHOWORLD tracked that year. Still, there’s reason for optimism and a livelier M&A market in the years ahead. Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions:
- Smith+Nephew acquired CartiHeal last November to capture the company’s novel technology for regenerating cartilage in the knee.
- Enovis acquired LimaCorporate in January to gain addition tractions in the extremities and reconstruction segments.
- Stryker acquired France-based SERF in December to add to its hip replacement portfolio across Europe.
- Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it completed its merger with NuVasive last September.
- restor3d acquired Conformis last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices.
ORTHOWORLD expects M&A deal volume to hold steady in 2024 amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market could become more active sometime in 2025 as interest in orthopedic targets remains strong.
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell